Analysis of Pseudomonas aeruginosa transcription in an ex vivo cystic fibrosis sputum model identifies metal restriction as a gene expression stimulus
暂无分享,去创建一个
[1] Application of a quantitative framework to improve the accuracy of a bacterial infection model , 2023, Proceedings of the National Academy of Sciences of the United States of America.
[2] L. Hoffman,et al. Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist , 2023, The Journal of clinical investigation.
[3] S. Nouraie,et al. Iron bioavailability regulates Pseudomonas aeruginosa interspecies interactions through type VI secretion expression , 2023, Cell reports.
[4] Alexandra J. Lee,et al. Compendium-Wide Analysis of Pseudomonas aeruginosa Core and Accessory Genes Reveals Transcriptional Patterns across Strains PAO1 and PA14 , 2022, mSystems.
[5] Alexandra J. Lee,et al. Computationally Efficient Assembly of Pseudomonas aeruginosa Gene Expression Compendia , 2022, mSystems.
[6] K. Perron,et al. Zinc homeostasis in Pseudomonas , 2022, BioMetals.
[7] B. Stanton,et al. ESKAPE Act Plus: Pathway Activation Analysis for Bacterial Pathogens , 2022, mSystems.
[8] V. Waters,et al. Opportunistic Pathogens in Cystic Fibrosis: Epidemiology and Pathogenesis of Lung Infection. , 2022, Journal of the Pediatric Infectious Diseases Society.
[9] Z. Gu. Complex heatmap visualization , 2022, iMeta.
[10] M. Greenwald,et al. The changing landscape of the cystic fibrosis lung environment: From the perspective of Pseudomonas aeruginosa. , 2022, Current opinion in pharmacology.
[11] D. Hogan,et al. Community composition shapes microbial-specific phenotypes in a cystic fibrosis polymicrobial model system , 2022, bioRxiv.
[12] J. Manos,et al. The Use of Artificial Sputum Media to Enhance Investigation and Subsequent Treatment of Cystic Fibrosis Bacterial Infections , 2022, Microorganisms.
[13] Anupama Khare,et al. Systematic identification of molecular mediators of interspecies sensing in a community of two frequently coinfecting bacterial pathogens , 2022, PLoS biology.
[14] Alexandra J. Lee,et al. CF-Seq, an accessible web application for rapid re-analysis of cystic fibrosis pathogen RNA sequencing studies , 2022, Scientific Data.
[15] C. Goss,et al. Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis Infections , 2021, mBio.
[16] M. Potvin,et al. Genome evolution drives transcriptomic and phenotypic adaptation in Pseudomonas aeruginosa during 20 years of infection , 2021, Microbial genomics.
[17] V. Abbate,et al. Effect of iron chelation on anti-pseudomonal activity of doxycycline , 2021, International journal of antimicrobial agents.
[18] V. Phelan,et al. Impact of Artificial Sputum Medium Formulation on Pseudomonas aeruginosa Secondary Metabolite Production , 2021, Journal of bacteriology.
[19] L. Hoffman,et al. Phenotypic characteristics of incident and chronic MRSA isolates in cystic fibrosis. , 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[20] Zhongyou Li,et al. GAUGE-Annotated Microbial Transcriptomic Data Facilitate Parallel Mining and High-Throughput Reanalysis To Form Data-Driven Hypotheses , 2021, mSystems.
[21] F. Vandenesch,et al. How Bacterial Adaptation to Cystic Fibrosis Environment Shapes Interactions Between Pseudomonas aeruginosa and Staphylococcus aureus , 2021, Frontiers in Microbiology.
[22] D. Hogan,et al. Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum , 2021, bioRxiv.
[23] Eun-Jeong Yoon,et al. Mobile Carbapenemase Genes in Pseudomonas aeruginosa , 2021, Frontiers in Microbiology.
[24] J. Boccard,et al. Metabotypes of Pseudomonas aeruginosa Correlate with Antibiotic Resistance, Virulence and Clinical Outcome in Cystic Fibrosis Chronic Infections , 2021, Metabolites.
[25] J. Emond‐Rheault,et al. A megaplasmid family driving dissemination of multidrug resistance in Pseudomonas , 2020, Nature Communications.
[26] Catherine A. Wakeman,et al. Pseudomonas aeruginosa polymicrobial interactions during lung infection. , 2020, Current opinion in microbiology.
[27] R. Rappuoli,et al. Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia. , 2020, Trends in microbiology.
[28] L. Chiarelli,et al. Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients , 2019, International journal of molecular sciences.
[29] S. Charman,et al. Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens: A Cohort Study Using National Registry Data. , 2019, Annals of the American Thoracic Society.
[30] Alexandra J. Lee,et al. Pseudomonas aeruginosa lasR mutant fitness in microoxia is supported by an Anr-regulated oxygen-binding hemerythrin , 2019, Proceedings of the National Academy of Sciences.
[31] Bradley S. Turner,et al. Mucin glycans attenuate the virulence of Pseudomonas aeruginosa in infection , 2019, Nature Microbiology.
[32] A. Haverich,et al. Genetically diverse Pseudomonas aeruginosa populations display similar transcriptomic profiles in a cystic fibrosis explanted lung , 2019, Nature Communications.
[33] L. Peixe,et al. Antibiotic resistance in Pseudomonas aeruginosa - Mechanisms, epidemiology and evolution. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[34] M. Wolfgang,et al. Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis , 2019, Science Translational Medicine.
[35] K. Pardesi,et al. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review , 2019, Front. Microbiol..
[36] S. Johnston. Genetic adaptation , 2018, The International Encyclopedia of Biological Anthropology.
[37] V. Waters,et al. Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis , 2018, Clinical Microbiology Reviews.
[38] M. Mastropasqua,et al. Efficient zinc uptake is critical for the ability of Pseudomonas aeruginosa to express virulence traits and colonize the human lung. , 2018, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[39] Katja Koeppen,et al. ScanGEO: parallel mining of high-throughput gene expression data , 2017, Bioinform..
[40] C. McDevitt,et al. The Metallophore Staphylopine Enables Staphylococcus aureus To Compete with the Host for Zinc and Overcome Nutritional Immunity , 2017, mBio.
[41] Jie Tan,et al. Unsupervised Extraction of Stable Expression Signatures from Public Compendia with an Ensemble of Neural Networks. , 2017, Cell systems.
[42] Jie Tan,et al. ADAGE signature analysis: differential expression analysis with data-defined gene sets , 2017, BMC Bioinformatics.
[43] R. Eils,et al. Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..
[44] S. Bleves,et al. The T6SSs of Pseudomonas aeruginosa Strain PAO1 and Their Effectors: Beyond Bacterial-Cell Targeting , 2016, Front. Cell. Infect. Microbiol..
[45] M. Whiteley,et al. Metabolism and Pathogenicity of Pseudomonas aeruginosa Infections in the Lungs of Individuals with Cystic Fibrosis , 2015, Microbiology spectrum.
[46] Elizabeth M. Nolan,et al. Human Calprotectin Is an Iron-Sequestering Host-Defense Protein , 2015, Nature chemical biology.
[47] Daniel S. Himmelstein,et al. Understanding multicellular function and disease with human tissue-specific networks , 2015, Nature Genetics.
[48] Roland Eils,et al. circlize implements and enhances circular visualization in R , 2014, Bioinform..
[49] S. Bell,et al. Elevated metal concentrations in the CF airway correlate with cellular injury and disease severity. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[50] M. Schurr,et al. Iron-Regulated Expression of Alginate Production, Mucoid Phenotype, and Biofilm Formation by Pseudomonas aeruginosa , 2014, mBio.
[51] A. Filloux. Faculty Opinions recommendation of A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. , 2013 .
[52] I. Schalk,et al. Pyoverdine biosynthesis and secretion in Pseudomonas aeruginosa: implications for metal homeostasis. , 2013, Environmental microbiology.
[53] J. Koo,et al. PilMNOPQ from the Pseudomonas aeruginosa Type IV Pilus System Form a Transenvelope Protein Interaction Network That Interacts with PilA , 2013, Journal of bacteriology.
[54] Sean R. Davis,et al. NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..
[55] C. W. Davis,et al. CFTR, mucins, and mucus obstruction in cystic fibrosis. , 2012, Cold Spring Harbor perspectives in medicine.
[56] R. Gambari,et al. Oxidative stress and antioxidant therapy in cystic fibrosis. , 2012, Biochimica et biophysica acta.
[57] B. Stanton,et al. Iron and CF‐related anemia: Expanding clinical and biochemical relationships , 2011, Pediatric pulmonology.
[58] J. Lipuma. The Changing Microbial Epidemiology in Cystic Fibrosis , 2010, Clinical Microbiology Reviews.
[59] Davis J. McCarthy,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[60] G. O’Toole,et al. Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. , 2009, American journal of respiratory cell and molecular biology.
[61] Sébastien Lê,et al. FactoMineR: An R Package for Multivariate Analysis , 2008 .
[62] B. Rubin. Mucus structure and properties in cystic fibrosis. , 2007, Paediatric respiratory reviews.
[63] Stephen Lory,et al. A Virulence Locus of Pseudomonas aeruginosa Encodes a Protein Secretion Apparatus , 2006, Science.
[64] N. Høiby,et al. Occurrence of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Patients Is Associated with the Oxidative Stress Caused by Chronic Lung Inflammation , 2005, Antimicrobial Agents and Chemotherapy.
[65] V. Deretic,et al. Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection , 1997, Infection and immunity.
[66] D. Hassett,et al. Fumarase C activity is elevated in response to iron deprivation and in mucoid, alginate-producing Pseudomonas aeruginosa: cloning and characterization of fumC and purification of native fumC , 1997, Journal of bacteriology.
[67] F. Neidhardt,et al. Culture Medium for Enterobacteria , 1974, Journal of bacteriology.
[68] B. Stanton,et al. Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells. , 2015, The Journal of antimicrobial chemotherapy.
[69] J. Walker,et al. Bacterial Pathogenesis , 2008, Methods in Molecular Biology™.
[70] J. Riordan. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA , 1989 .